tradingkey.logo
tradingkey.logo
Buscar

West Pharmaceutical Services Inc

WST
Añadir a la lista de seguimiento
325.920USD
+3.910+1.21%
Cierre 05/08, 16:00ETCotizaciones retrasadas 15 min
23.11BCap. mercado
43.35P/E TTM

West Pharmaceutical Services Inc

325.920
+3.910+1.21%

Más Datos de West Pharmaceutical Services Inc Compañía

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Información de West Pharmaceutical Services Inc

Símbolo de cotizaciónWST
Nombre de la empresaWest Pharmaceutical Services Inc
Fecha de salida a bolsaSep 01, 2059
Director ejecutivoGreen (Eric Mark)
Número de empleados10600
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 01
Dirección530 Herman O. West Drive
CiudadEXTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal19341
Teléfono16105942900
Sitio Webhttps://www.westpharma.com/
Símbolo de cotizaciónWST
Fecha de salida a bolsaSep 01, 2059
Director ejecutivoGreen (Eric Mark)

Ejecutivos de West Pharmaceutical Services Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
179.49K
+4.66%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.63K
-0.77%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
43.66K
+1.65%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
43.52K
+1.65%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
22.75K
+3.97%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
18.57K
-2.36%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
9.99K
-4.71%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Lead Independent Director
Lead Independent Director
3.65K
-13.49%
Mr. Shane Campbell
Mr. Shane Campbell
Senior Vice President, Chief Proprietary Segment Officer
Senior Vice President, Chief Proprietary Segment Officer
3.12K
--
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
2.73K
+20.83%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
179.49K
+4.66%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.63K
-0.77%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
43.66K
+1.65%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
43.52K
+1.65%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
22.75K
+3.97%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
18.57K
-2.36%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
High Value Components
1.44B
47.00%
Standard Packaging
645.56M
21.00%
Contract-Manufactured Products
584.08M
19.00%
Delivery Devices
399.63M
13.00%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.33B
43.25%
Other European Countries
451.00M
14.67%
Germany
380.30M
12.37%
Other
353.30M
11.49%
Ireland
333.30M
10.84%
France
226.60M
7.37%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
High Value Components
1.44B
47.00%
Standard Packaging
645.56M
21.00%
Contract-Manufactured Products
584.08M
19.00%
Delivery Devices
399.63M
13.00%

Estadísticas de accionistas

Actualizado: mié., 6 de may
Actualizado: mié., 6 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
13.06%
BlackRock Institutional Trust Company, N.A.
5.45%
State Street Investment Management (US)
4.60%
Artisan Partners Limited Partnership
4.03%
Brown Advisory
2.75%
Otro
70.10%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
13.06%
BlackRock Institutional Trust Company, N.A.
5.45%
State Street Investment Management (US)
4.60%
Artisan Partners Limited Partnership
4.03%
Brown Advisory
2.75%
Otro
70.10%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
50.66%
Investment Advisor/Hedge Fund
34.40%
Pension Fund
4.08%
Hedge Fund
3.27%
Research Firm
2.89%
Bank and Trust
1.65%
Sovereign Wealth Fund
1.56%
Insurance Company
0.77%
Individual Investor
0.64%
Otro
0.06%

Participación institucional

Actualizado: dom., 5 de abr
Actualizado: dom., 5 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q4
1307
70.33M
100.32%
--
2026Q1
1656
70.67M
100.03%
-2.92M
2025Q4
1651
70.41M
97.87%
-4.01M
2025Q3
1640
70.77M
98.37%
-2.34M
2025Q2
1636
72.03M
100.16%
-1.82M
2025Q1
1662
71.25M
99.16%
-2.66M
2024Q4
1626
70.93M
98.10%
-2.28M
2024Q3
1603
70.42M
97.07%
-3.49M
2024Q2
1609
70.03M
96.14%
-3.89M
2024Q1
1617
70.47M
96.25%
-3.65M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
9.51M
13.19%
-166.41K
-1.72%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.85M
5.34%
+53.24K
+1.40%
Dec 31, 2025
State Street Investment Management (US)
3.25M
4.51%
+44.11K
+1.38%
Dec 31, 2025
Artisan Partners Limited Partnership
2.85M
3.95%
+79.48K
+2.87%
Dec 31, 2025
Brown Advisory
1.94M
2.7%
-554.48K
-22.20%
Dec 31, 2025
Geode Capital Management, L.L.C.
1.87M
2.59%
+11.96K
+0.64%
Dec 31, 2025
Walter Scott & Partners Ltd.
1.75M
2.43%
-178.46K
-9.23%
Dec 31, 2025
Generation Investment Management LLP
1.56M
2.17%
+585.86K
+60.03%
Dec 31, 2025
APG Asset Management N.V.
1.20M
1.66%
-214.69K
-15.19%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
1.17M
1.63%
+473.55K
+67.51%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Motley Fool Mid-Cap Growth ETF
3.52%
VanEck Morningstar Wide Moat ETF
2.83%
First Trust Indxx Medical Devices ETF
2.15%
VanEck Morningstar Wide Moat Value ETF
2.14%
Invesco S&P 500 Equal Weight Health Care ETF
1.8%
Nuveen ESG Mid-Cap Growth ETF
1.72%
American Century Mid Cap Growth Impact ETF
1.63%
Hilton Small-MidCap Opportunity ETF
1.51%
iShares Health Innovation Active ETF
1.5%
ProShares S&P 500 Dividend Aristocrats ETF
1.46%
Ver más
Motley Fool Mid-Cap Growth ETF
Proporción3.52%
VanEck Morningstar Wide Moat ETF
Proporción2.83%
First Trust Indxx Medical Devices ETF
Proporción2.15%
VanEck Morningstar Wide Moat Value ETF
Proporción2.14%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.8%
Nuveen ESG Mid-Cap Growth ETF
Proporción1.72%
American Century Mid Cap Growth Impact ETF
Proporción1.63%
Hilton Small-MidCap Opportunity ETF
Proporción1.51%
iShares Health Innovation Active ETF
Proporción1.5%
ProShares S&P 500 Dividend Aristocrats ETF
Proporción1.46%

Dividendos

Un total de 221.30M USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 17, 2026
WST.NB Interim Cash Dividend of gross USD 0.22 paid on May 06, 2026 going ex on Apr 29, 2026
Apr 29, 2026
May 06, 2026
Apr 29, 2026
Dec 10, 2025
WST.NB Interim Cash Dividend of gross USD 0.22 paid on Feb 04, 2026 going ex on Jan 28, 2026
Jan 28, 2026
Feb 04, 2026
Jan 28, 2026
Jul 24, 2025
WST.NB Final Cash Dividend of gross USD 0.22 paid on Nov 19, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 19, 2025
Nov 12, 2025
Apr 24, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Aug 06, 2025 going ex on Jul 30, 2025
Jul 30, 2025
Aug 06, 2025
Jul 30, 2025
Feb 20, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on May 07, 2025 going ex on Apr 30, 2025
Apr 30, 2025
May 07, 2025
Apr 30, 2025
Jan 28, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Feb 11, 2025 going ex on Feb 07, 2025
Feb 07, 2025
Feb 11, 2025
Feb 07, 2025
Oct 24, 2024
WST.NB Final Cash Dividend of gross USD 0.21 paid on Nov 20, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 20, 2024
Nov 13, 2024
Apr 25, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Aug 07, 2024 going ex on Jul 31, 2024
Jul 31, 2024
Aug 07, 2024
Jul 31, 2024
Feb 20, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on May 01, 2024 going ex on Apr 23, 2024
Apr 24, 2024
May 01, 2024
Apr 23, 2024
Dec 06, 2023
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 07, 2024 going ex on Jan 30, 2024
Jan 31, 2024
Feb 07, 2024
Jan 30, 2024
Ver más

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI